S 1954 · 119th Congress
Biosimilar Red Tape Elimination Act
This bill aims to reduce regulatory requirements for biosimilar drugs—which are lower-cost copies of expensive biologic medications that work essentially the same way as the original drugs. Right now, when a company wants to bring a biosimilar to market, they have to go through extensive testing and paperwork to pro…
- Sponsor
- Lee, Mike (R-Utah)
- Introduced
- 2025-06-04
- Policy area
- Health
- Latest action
- Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.
Digging through Congress... 🔍